Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduction of ischemia-reperfusion injury by ex vivo tacrolimus perfusion of marginal livers before transplantation
2010-021333-31Phase 3Terminated
- Sponsor
- LMU Klinikum
- Start
- Jun 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tacrolimus in hepatic failure and decompensated cirrhosis, sponsored by LMU Klinikum. Primary endpoint: Maximum GPT within first 48 hours. Started Jun 2011; status: terminated.
02
Drugs
tacrolimus
03
Conditions
hepatic failuredecompensated cirrhosis
Beyond the preview
Go deeper on 2010-021333-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021333-31.